| Name | Title | Contact Details |
|---|---|---|
William Emfinger |
Director R&D | Profile |
Marcus Hoover |
Director of Talent Acquisition - Americas | Profile |
Dan Debrah |
Vice President Research And Development | Profile |
Carl Bandhold |
Chief Financial Officer | Profile |
Charlotta Nyberg |
Chief Financial Officer | Profile |
MDIC is the one place where industry, non-profits, academia & government can collaborate to make patient access to new medical device technologies faster, safer and more cost-effective. MDIC is a public-private partnership facilitating collaboration within the medical device industry. We coordinate the development of methods, tools, and resources used in managing the total product life cycle of a medical device to improve patient access to cutting-edge medical technology.
centennial medical group is a Ellicott City, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Crossroads Medical Associates is a Ellicott City, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InTouch Health is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.